Dr. Espinoza is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1550 N 115th St
Seattle, WA 98133Phone+1 206-520-5000
Summary
- Randall Espinoza, MD, MPH is currently Professor of Clinical Psychiatry in the Division of Geriatric Psychiatry, Department of Psychiatry and Biobehavioral Sciences at UCLA and holds the Muriel Harris Endowed Chair in Geriatric Psychiatry. From 2007 to 2009 he served as Chief of Staff of the Resnick Neuropsychiatric Hospital at UCLA. From 2009 to 2022, he served as the Training Director of the UCLA Geriatric Psychiatry Fellowship Program. Since 2000 he has been Medical Director of the UCLA RNPH Electroconvulsive Therapy and Interventional Psychiatry Program. He also serves on the Medical IRB-3 of the UCLA School of Medicine. He received his BS degree in Bioengineering from Columbia University in New York, MD from the University of Texas Southwestern Medical School in Dallas, and Executive MPH from the University of California, Los Angeles School of Public Health. He completed psychiatry residency training at UT Southwestern / Parkland Memorial Hospital in Dallas, at UNC Hospitals in Chapel Hill, NC, and at the Olive View-UCLA Hospitals. He completed a geriatric psychiatry fellowship at the UCLA NPI and has expertise in ECT, VNS, TMS, DBS and other interventional methods. He is a Master Educator with certification from the Association for Academic Psychiatry and completed the UCLA Medical Faculty Fellowship program. In 2002 he received the Outstanding House Staff Teaching Award from the UCLA Department of Psychiatry, and in 2003 he received a Geriatric Academic Career Development Award (K01) from the Human Resources and Services Administration of the U.S. Department of Health and Human Services. He is actively involved in professional and scientific societies, and also serves on the editorial boards of or as reviewer for top medical and psychiatric journals. He has an active clinical and forensic practice as well as ongoing research portfolio in neuromodulation, treatment-resistant depression and medical and inter-professional training and education.
Education & Training
- International Society for ECT and NeurostimulationCertificate, 2013
- UCLACertification, Deep Brain Stimulation, 2011
- International Society for ECT and NeurostimulationCertification, Transcranial Magnetic Stimulation, 2009
- Cyberonics, INCCertificate, Vagus Nerve Stimulation, 2005
- Association for Convulsive TherapyCertificate, ECT, 2000
- Association of Academic PsychiatryME, Master Educator, 2004 - 2007
- Ronald Reagan UCLA Medical CenterFaculty Medical Education, 2003 - 2005
- UCLA School of Public HealthMPH, Executive Health Services, 2000 - 2002
- UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Psychiatry, 1994 - 1996
- UCLA David Geffen School of Medicine/UCLA Medical Center/VA Greater Los Angeles Healthcare SystemResidency, Psychiatry, 1992 - 1994
- University of North Carolina HospitalsResidency, Psychiatry, 1991 - 1992
- University of Texas M D Anderson Cancer CenterInternship, Transitional Year, 1990 - 1991
- University of Texas Southwestern Medical SchoolClass of 1990
Certifications & Licensure
- CA State Medical License 1992 - 2026
- WA State Medical License 2024 - 2025
- NC State Medical License 1991 - 1999
- TX State Medical License 1991 - 1997
- American Board of Psychiatry and Neurology Psychiatry
- American Board of Psychiatry and Neurology Geriatric Psychiatry
Awards, Honors, & Recognition
- Membership American College of Psychiatry, 2020
- Muriel Harris Chair of Geriatric Psychiatry UCLA, 2014
- Best Doctors in LA Los Angeles Magazine, 2010-2012
- Join now to see all
Clinical Trials
- Use of Risperidone in ECT for Treatment Resistant Depression Start of enrollment: 2005 Mar 01
- Biomarkers of Fast Acting Therapies in Major Depression Start of enrollment: 2014 Jun 01
- Tractography Guided Subcallosal Cingulate Deep Brain Stimulation for Treatment Resistant Depression Start of enrollment: 2022 Oct 28
Publications & Presentations
PubMed
- 24 citationsModulation of inhibitory control networks relate to clinical response following ketamine therapy in major depression.Ashish Sahib, Joana Loureiro, Megha Vasavada, Antoni Kubicki, Benjamin S. C. Wade
Translational Psychiatry. 2020-07-30 - 13 citationsNeuroimaging-Derived Biomarkers of the Antidepressant Effects of Ketamine.Artemis Zavaliangos-Petropulu, Noor B Al-Sharif, Brandon Taraku, Amber M Leaver, Ashish K Sahib
Biological Psychiatry. Cognitive Neuroscience and Neuroimaging. 2023-04-01 - 32 citationsEffects of Serial Ketamine Infusions on Corticolimbic Functional Connectivity in Major Depression.Megha Vasavada, Joana Loureiro, Antoni Kubicki, Ashish Sahib, Benjamin Wade
Biological Psychiatry. Cognitive Neuroscience and Neuroimaging. 2021-07-01
Other
- Diagnosis and management of late-life depressionEspinoza RT, Uní_tzer J
http://www.uptodate.com/contents/diagnosis-and-management-of-late-life-depression
UpToDate, Wolters Kluwer Health - 2013-04-04
Committees
- Scientific member, Ad Hoc Chair, Medical IRB-3 Psychiatry and Neurology 2006 - Present
Professional Memberships
- Member
- American Association for Geriatric PsychiatryMember
- Association for Academic PsychiatryMember
- International Society for ECT and NeurostimulationMember
- Organization for Human Brain MappingMember
Other Languages
- Spanish
External Links
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: